Cargando…
Soluble LOX‐1: A Novel Biomarker in Patients With Coronary Artery Disease, Stroke, and Acute Aortic Dissection?
Autores principales: | Hofmann, Anja, Brunssen, Coy, Wolk, Steffen, Reeps, Christian, Morawietz, Henning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988168/ https://www.ncbi.nlm.nih.gov/pubmed/31902328 http://dx.doi.org/10.1161/JAHA.119.013803 |
Ejemplares similares
-
Associations of Tissue and Soluble LOX‐1 with Human Abdominal Aortic Aneurysm
por: Hofmann, Anja, et al.
Publicado: (2023) -
Pharmacotherapies and Aortic Heme Oxygenase-1 Expression in Patients with Abdominal Aortic Aneurysm
por: Hofmann, Anja, et al.
Publicado: (2022) -
Induction of Heme Oxygenase‐1 Is Linked to the Severity of Disease in Human Abdominal Aortic Aneurysm
por: Hofmann, Anja, et al.
Publicado: (2021) -
NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice
por: Langbein, Heike, et al.
Publicado: (2016) -
Cardiac‐Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers
por: Dewey, Colleen M., et al.
Publicado: (2016)